Consentement d'utilisation des Cookies

J'accepte. Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques.Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur vous nous accordez la permission de conserver des informations sur votre appareil.

Endothelial Cell Growth Supplement, bovine hypothalamus, BT-203 - Endothelial Mitogen - ECGS - J64516 - Alfa Aesar

J64516 Endothelial Cell Growth Supplement, bovine hypothalamus, BT-203

Numéro de CAS
Synonymes
Endothelial Mitogen
ECGS

Conditionnement Prix ($) Quantité Disponibilité
50mg 94,40
10x50mg 785,00
Ajouter au panier Ajouter au devis en vrac Afficher l'article

Endothelial Cell Growth Supplement, bovine hypothalamus, BT-203

MDL
MFCD00146844

Propriétés chimiques

Forme
Lyophilized powder

Applications

Endothelial Mitogen (ECGS) is a partially purified preparation from bovine hypothalamus. Endothelial Mitogen was originally prepared to facilitate the growth and survival of human (or mammalian) vascular endothelial cells in vitro. Our ECGS is used to improve growth, supplement and/or reduce serum concentrations in cultures of endothelial cells, Balb/C-3T3 cells and in hybridoma cell cloning. Optimal concentration range is from 25-200µg/ml. Our ECGS does not contain streptomycin, which may be toxic to cellsEndothelial Cell Growth Supplement, bovine hypothalamus is an extract of bovine neural tissue containing growth promoting factors for vascular endothelial cells of mammalian origin. It has also been reported to be beneficial as a media supplement for the fusion and growth of hybridoma cells in monoclonal antibody production. In addition to this it is used for the culture of many other cell types, including human keratinocytes.

Notes

Store in a cool place. Incompatible with strong oxidizing agents.

Références bibliographiques

O'Leary, A. P.; Fox, J. M.; Pullar, C. E. Beta-Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP-Dependent Mechanism and Wound Angiogenesis. J. Cell. Physiol. 2015, 230 (2), 356-365.

Sarmiento, D.; Montorfano, I.; Cerda, O.; Cáceres, M.; Becerra, A.; Cabello-Verrugio, C.; Elorza, A. A.; Riedel, C.; Tapia, P.; Velásquez, L. A.; Varela, D.; Simon, F. Increases in reactive oxygen species enhance vascular endothelial cell migration through a mechanism dependent on the transient receptor potential melastatin 4 ion channel. Microvasc. Res. 2015, 98, 187-196.

Autres références

Code tarifaire harmonisé
2937.19
TSCA
No

Recommandé

  • H33953

    2-Bromo-5-fluoro-3-methylpyridine, 97%
  • 11440

    Silver foil, 0.127mm (0.005in) thick, annealed, 99.9% (metals basis)
  • B21970

    4,4'-Diiodobiphenyl, 99%
  • J60028

    TB Solution-II
  • A18250

    4-Fluoro-3-(trifluoromethyl)aniline, 98%

Consulté récemment

Produits chimiques

Sciences de la vie

Métaux et matériaux

Catalyseurs

Analytique et matériel de laboratoire